Philips and Accenture develop ALS care proof of concept on top of Emotiv brain wave headset
Philips, Accenture test brain-controlled system for ALS patients (Reuters):
“The Netherlands’ Royal Philips and IT consultancy Accenture are developing software to help people with neurodegenerative diseases like amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s disease, live more independently.
The companies said they have built a trial application that lets patients with ALS, a disease that diminishes muscle action, issue “brain commands” to turn lights on and off or send an alert to a doctor.
The software works by connecting a wireless headset developed by Emotiv, a San Francisco-based startup, to a wearable device. Emotiv says its headset can read brain waves and translate them into readable data, which is then used to issue commands to Philips’ existing connected products such as “smart” TVs and lighting systems.”
Accenture and Philips stress their app is a “proof of concept” but said they have tested it with patients…”
Learn more:
- Infographic on the Digital Brain Health Market 2012–2020
- 2014 SharpBrains Virtual Summit (October 28–30th, 2014)